Pitié-Salpêtrière University Hospital is a teaching hospital in the 13th arrondissement of Paris. Part of the Assistance Publique – Hôpitaux de Paris and a teaching hospital of Sorbonne University, it is one of Europe's largest hospitals. It is also France's largest hospital.

During the past decade, Ch Pitie Salpetriere; Rhumatologie conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Ch Pitie Salpetriere; Rhumatologie" are "Rheumatoid Arthritis" (2 trials). Many other conditions were trialed in "Ch Pitie Salpetriere; Rhumatologie" in a lesser frequency.

Most popular intervention types in "Ch Pitie Salpetriere; Rhumatologie" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Methotrexate" (2 trials), "Tocilizumab" (2 trials), "Placebo to methotrexate" (1 trials) and "Placebo to tocilizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ch Pitie Salpetriere; Rhumatologie" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Ch Pitie Salpetriere; Rhumatologie". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Ch Pitie Salpetriere; Rhumatologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ch Pitie Salpetriere; Rhumatologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".